Cargando…

EPIDEMIOLOGY OF PARKINSON'S DISEASE

Mostrar otras versiones (2)

Detalles Bibliográficos
Autores principales:	Tanner, Caroline M., Goldman, Samuel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	W. B. Saunders Company. Published by Elsevier Inc. 1996
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173037/ https://www.ncbi.nlm.nih.gov/pubmed/8827174 http://dx.doi.org/10.1016/S0733-8619(05)70259-0

Ejemplares similares

Epidemiology of Parkinson’s Disease
por: Tanner, Caroline M.
Publicado: (1992)

Epidemiology of Parkinson's disease
por: Kasten, Meike, et al.
Publicado: (2007)

Electrocardiographic changes predate Parkinson’s disease onset
por: Akbilgic, Oguz, et al.
Publicado: (2020)

The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
por: Brown, Ethan G., et al.
Publicado: (2020)

Trichloroethylene: An Invisible Cause of Parkinson’s Disease?
por: Dorsey, E. Ray, et al.
Publicado: (2023)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

Predicting Parkinson’s Disease and Its Pathology via Simple Clinical Variables
por: Karabayir, Ibrahim, et al.
Publicado: (2022)

Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
por: Karabayir, Ibrahim, et al.
Publicado: (2023)

Gradient boosting for Parkinson’s disease diagnosis from voice recordings
por: Karabayir, Ibrahim, et al.
Publicado: (2020)

Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease
por: Do, Chuong B., et al.
Publicado: (2011)

Preventing Parkinson’s Disease: An Environmental Agenda
por: De Miranda, Briana R., et al.
Publicado: (2022)

Proposal for a Biologic Staging System of Parkinson’s Disease
por: Chahine, Lana M., et al.
Publicado: (2023)

Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson’s disease
por: Hauser, Robert A., et al.
Publicado: (2022)

Epidemiology of Parkinsonism and Parkinson's disease in Sub-Saharan Africa: Nigerian profile
por: Akinyemi, Rufus O
Publicado: (2012)

Pain Severity and Interference in Different Parkinson’s Disease Cognitive Phenotypes
por: Cruz-Almeida, Yenisel, et al.
Publicado: (2020)

Epidemiological Evidence for an Immune Component of Parkinson’s Disease
por: Gonzalez-Latapi, Paulina, et al.
Publicado: (2022)

The Impact of the COVID‐19 Pandemic on Care Partners of People with Parkinson's Disease
por: Speelberg, Daniël H.B., et al.
Publicado: (2023)

Predictors of time to initiation of symptomatic therapy in early Parkinson's disease
por: Simuni, Tanya, et al.
Publicado: (2016)

The Epidemiology and Clinical Manifestations of Dysexecutive Syndrome in Parkinson’s Disease
por: Ceravolo, Roberto, et al.
Publicado: (2012)

Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and Dyskinesia
por: Mehta, Shyamal H., et al.
Publicado: (2021)

Current and projected future economic burden of Parkinson’s disease in the U.S.
por: Yang, Wenya, et al.
Publicado: (2020)

Incidence of Parkinson disease in North America
por: Willis, A. W., et al.
Publicado: (2022)

Burden of Parkinsonism and Parkinson’s Disease on Health Service Use and Outcomes in Latin America
por: Kim, Dani J., et al.
Publicado: (2023)

Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease
por: Bock, Meredith A., et al.
Publicado: (2022)

Clinical and Epidemiological Factors Associated with Mortality in Parkinson's Disease in a Brazilian Cohort
por: Fernandes, Gustavo Costa, et al.
Publicado: (2015)

Clinical and Epidemiological Aspects of Parkinson's Disease in the South of Western Siberia
por: Rozhdestvensky, Alexey Sergeevich, et al.
Publicado: (2020)

MEX-PD: A National Network for the Epidemiological & Genetic Research of Parkinson’s Disease
por: Lázaro-Figueroa, Alejandra, et al.
Publicado: (2023)

Cognition and connectomes in nondementia idiopathic Parkinson’s disease
por: Colon-Perez, Luis M., et al.
Publicado: (2018)

Sleep disturbances and depression severity in patients with Parkinson's disease
por: Kay, Daniel B., et al.
Publicado: (2018)

New Thoughts on Thought Disorders in Parkinson's Disease: Review of Current Research Strategies and Challenges
por: Goldman, Jennifer G.
Publicado: (2011)

Recruitment for Remote Decentralized Studies in Parkinson’s Disease
por: Myers, Taylor L., et al.
Publicado: (2022)

Descriptive epidemiological study on patients with movement disorders, with emphasis on Parkinson’s disease
por: Balestrassi, Luiza Serafini, et al.
Publicado: (2020)

Deep Learning for Daily Monitoring of Parkinson’s Disease Outside the Clinic Using Wearable Sensors
por: Atri, Roozbeh, et al.
Publicado: (2022)

The Changing Landscape of Parkinson Epidemiologic Research
por: Chen, Honglei
Publicado: (2018)

Meeting Report: Consensus Statement—Parkinson’s Disease and the Environment: Collaborative on Health and the Environment and Parkinson’s Action Network (CHE PAN) Conference 26–28 June 2007
por: Bronstein, Jeff, et al.
Publicado: (2009)

Changes in Epidemiological Trends and Rehabilitation Usage in Neurological Diseases in Korea: Parkinson's Disease
por: Yun, Seo Jung, et al.
Publicado: (2021)

Early detection of Parkinson’s disease through enriching the electronic health record using a biomedical knowledge graph
por: Soman, Karthik, et al.
Publicado: (2023)

Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study)
por: Pahwa, Rajesh, et al.
Publicado: (2015)

Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences
por: Sergi, Domenico, et al.
Publicado: (2019)

Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies
por: Zhang, Jun-Fang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b2g6o2fsuetktq27ancm2me20f